About The Study: The results of this systematic review and meta-analysis suggest that integrating magnetic resonance imaging (MRI) in prostate cancer screening pathways is associated with a reduced number of unnecessary biopsies and overdiagnosis of insignificant prostate cancer while maintaining clinically significant prostate cancer detection as compared with prostate-specific antigen (PSA)-only screening.
Authors: Shahrokh F. Shariat, M.D., D.Dr.(hc), of Medical University Vienna in Vienna, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2024.0734)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Media advisory: This study is being released to coincide with presentation at the 39th Annual European Association of Urology Congress.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.0734?guestAccessKey=631de277-a867-4cac-926c-f85b41ec167e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040524
JAMA Oncology